Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
#AscendisPharma #NovoNordisk #TransConTechnology #MetabolicDiseases #CardiovascularDiseases #Biopharma #HealthcareInnovation #GLP1 bioSeedins Post Ascendis Pharma (Nasdaq: ASND) Ascendis Pharma has granted Novo Nordisk (NYSE: NVO) Novo Nordisk an exclusive license to use its TransCon technology platform for developing treatments in metabolic diseases, including obesity and type 2 diabetes, and on a product-specific basis for cardiovascular diseases
$5.00 $8.50Price range: $5.00 through $8.50 Related Products Related products Peptides Wolverine $55.00 $75.00Price range: $55.00 through $75.00 Select options This product has multiple variants
We usually think of medication as a treatment, but thats changing
Despite this, the effects linked to loss of muscle mass are raising several concerns
US$ 25.25
US$ 21.29
US$ 23.10
US$ 24.86
US$ 25.32
US$ 20.42
